Call for Qld dogs to participate in cancer trial

Dr Richard Mollard of PharmAust said there the Perth-based biotechnology company was looking for more dogs diagnosed with B cell lymphoma to participate in Phase IIb of a study to help evaluate a newly formulated anti-cancer drug called Monepantel (MPL), normally used to worm sheep and goats.The Chief Scientific Officer said there was no known cure for B cell lymphomas, which are a type of blood cancers that can affect the lymph nodes.“Usually, only 50 per cent of dogs with B cell lymphoma will…



Click here to view the original article.